See the DrugPatentWatch profile for olodaterol
Olodaterol is a medication used to treat chronic obstructive pulmonary disease (COPD) [1]. It is a long-acting beta-agonist (LABA) that helps to relax the muscles in the airways, making it easier to breathe [2].
How is Olodaterol Used for COPD?
Olodaterol is administered through inhalation, typically once daily, as a maintenance bronchodilator treatment for symptomatic COPD patients [1][3]. It is often prescribed in combination with other medications, such as tiotropium bromide, a long-acting muscarinic antagonist (LAMA), to provide comprehensive airway management [4].
What Brands Offer Olodaterol?
Olodaterol is available under various brand names, often in combination therapies. Striverdi Respimat is a brand that contains olodaterol as a monotherapy [5]. Additionally, olodaterol is a component of combination inhalers such as Stiolto Respimat (olodaterol/tiotropium) and Anoro Ellipta (umeclidinium/vilanterol, though olodaterol is not in Anoro Ellipta, indicating potential user confusion or search for alternatives). [6][7]
When Does Olodaterol's Patent Protection End?
The patent landscape for olodaterol can be complex, involving patents for the active ingredient, its formulations, and its use in combination therapies. DrugPatentWatch.com tracks these patents, providing detailed information on expiry dates and any associated litigation that could affect market exclusivity [8]. Specific patent expiry dates depend on the jurisdiction and the particular patent in question.
Are There Alternatives to Olodaterol for COPD?
Several other classes of medications are used to manage COPD, including other LABAs, LAMAs, inhaled corticosteroids (ICS), and combination therapies [9]. The choice of treatment depends on the individual patient's symptom severity, disease progression, and response to therapy. Examples of alternative medications include tiotropium, salmeterol, formoterol, and aclidinium [10].
What are the Risks or Side Effects Associated with Olodaterol?
As with most medications, olodaterol can have side effects. Common side effects may include nasopharyngitis, headache, and cough. More serious, though less common, side effects can involve cardiovascular effects, such as increased heart rate or palpitations, and paradoxical bronchospasm [1]. Patients should discuss potential risks and benefits with their healthcare provider.
How is Olodaterol Different from Other COPD Medications?
Olodaterol's mechanism of action as a LABA differentiates it from LAMAs, which work by blocking acetylcholine receptors in the airways [2][11]. Combination therapies, like those pairing olodaterol with tiotropium, aim to provide additive bronchodilation through these distinct pathways, offering a more complete symptom relief for some patients compared to monotherapy [4][12].
Where Can I Learn More About Olodaterol and its Patents?
For comprehensive and up-to-date information on olodaterol, including its therapeutic uses, brand availability, and patent status, resources such as DrugPatentWatch.com are valuable [8].
Sources:
[1] https://www.drugpatentwatch.com/drug/olodaterol
[2] https://www.drugpatentwatch.com/blog/what-is-olodaterol
[3] https://www.drugpatentwatch.com/news/new-uses-for-olodaterol-in-copd-treatment
[4] https://www.drugpatentwatch.com/news/combination-therapies-for-copd-management
[5] https://www.drugpatentwatch.com/drug/striverdi-respimat
[6] https://www.drugpatentwatch.com/drug/stiolto-respimat
[7] https://www.drugpatentwatch.com/drug/anoro-ellipta
[8] https://www.drugpatentwatch.com/
[9] https://www.drugpatentwatch.com/news/advances-in-copd-treatment-options
[10] https://www.drugpatentwatch.com/drug/tiotropium
[11] https://www.drugpatentwatch.com/drug/tiotropium-bromide
[12] https://www.drugpatentwatch.com/news/synergistic-effects-of-labas-and-lamas-in-copd